Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Am Heart J. 2023 Jun 12;264:153–162. doi: 10.1016/j.ahj.2023.06.005

Table 2.

Percent of Late Gadolinium Enhancement Detected in Children with Hypertrophic Cardiomyopathy

Age group,
years
%LGE %LGE
>2%
LV Mass
adjusted
for BSA,
gni/m2
LV Mass
to
LVEDV
(gm/ml)
LV Mass
to
LVESV
(gm/ml)
Interventricular
septal
thickness
adjusted for
BSA, mm/m2
N Median
(25%, 75%)
N Median
(25%,
75%)
N Median
(25%,
75%)
N Median
(25%,
75%)
N Median
(25%,
75%)
N Median
(25%,
75%)
Overall 5 6.0 (2.0, 3 9.0 5 94.3 5 1.3 5 4.9 63 11.6 (6.8,16.2)
Birth to 5 6 11.5 (9.0,13.0) 6 11.5(9.0,13.0) 6 94.3(78.0,138.3) 6 1.3(1.1,1.4) 6 5.4(2.7,6.8) 10 18.4 (11.5,24.9)
6 to 10 13 7.0 (3.0, 8.0) 10 7.0(6.0,9.0) 13 81.2(74.9,89.2) 13 1.2(0.9,1.3) 13 5.0(3.4,6.5) 14 13.7 (12.0,16.2)
11 to 15 28 4.5 (1.0, 9.5) 18 8.0(5.0,14.0) 28 104.3(68.7,121.9) 27 1.4(0.9,1.6) 27 4.6(3.0,7.8) 33 10.2 (6.6,13.5)
16+ 5 7.0 (1.0,11.0) 3 11.0(7.0,14.0) 5 77.6(74.9,114.8) 5 1.3(0.9,1.4) 5 4.2(2.8,5.2) 6 7.6 (5.6,10.2)

Abbreviations: BSA, body surface area; LV, left ventricle; LVEDV, left ventricular end- diastolic volume; LVESV, left ventricular end-systolic volume; %LGE, percent late gadolinium enhancement.